The Senate Committee on Health,…
The Senate Committee on Health, Education, Labor and Pensions (HELP) [...]
Fosun Pharma subsidiary Henlius…
Fosun Pharma subsidiary Henlius Biotech has signed a $440 million [...]
Acadia Pharmaceuticals’ phase 2…
Acadia Pharmaceuticals’ phase 2 Alzheimer’s disease trial has missed its primary [...]
Merck & Co.’s Brunello trial…
Merck & Co.’s Brunello trial has hit its primary endpoint, [...]
Roche has penned a backloaded $2…
Roche has penned a backloaded $2 billion deal with hematology [...]
The Department of War has awarded…
The Department of War has awarded Flagship Pioneering $47 million [...]
Enveda has raised a $311 million…
Enveda has raised a $311 million series E round, positioning [...]
Immunovant has stopped development…
Immunovant has stopped development of IMVT-1402 in cutaneous lupus erythematosus [...]
As an imposing new competitor…
As an imposing new competitor begins to take shape, radiopharma [...]
Celldex touted a double phase 3…
Celldex touted a double phase 3 trial win in patients [...]